Big Cypress (BCYP) Shareholders Approve SAB Therapeutics Deal
Big Cypress Acquisition Corp. (NASDAQ:BCYP) secured shareholder approval of its combination with clinical-stage biopharmaceutical company SAB Biotherapeutics in a special meeting held yesterday. Approximately 98.3% of the votes cast at the meeting, representing approximately 78.6% of Big Cypress’ outstanding shares, were cast in favor of the proposal to approve the business combination. The 8-K filingRead More